Endologix Initiates Percutaneous Transmural Arterial Bypass (PTAB)1 Post-Market Study
IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional... Read more.
Natera to Participate in March Investor Conferences
AUSTIN, Texas–(BUSINESS WIRE)–Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will participate in the... Read more.
Destroy Duchenne selects DNA Nanobots as Partner to Develop Non-Viral Gene Delivery Solution for Duchenne Muscular Dystrophy
DMD patient and advocate Elijah Stacy’s non-profit foundation chooses a targeted dystrophin gene therapy approach using DNA nanoparticles to overcome limitations... Read more.
AppLovin Announces Pricing of Secondary Public Offering of Common Stock and Concurrent Share Repurchase
PALO ALTO, Calif.–(BUSINESS WIRE)–AppLovin Corporation (NASDAQ: APP) (“AppLovin” or the “Company”), a leading marketing platform, today announced... Read more.
Global Family Offices Database 2024: Asset Allocation, Investments, Management, and Investment Personnel by Name and Job Title, and Many with Emails – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Family Offices” database has been added to ResearchAndMarkets.com’s offering. Online database with... Read more.
FourKites Premier Carriers Deliver Outsized Growth in Second Half of 2023
Data suggests cautious optimism for recovery within freight sector, looking forward AMSTERDAM–(BUSINESS WIRE)–Leading real-time supply chain visibility... Read more.
State Street Announces $100 Million Program for Minority Depository Institutions and Community Development Financial Institutions
BOSTON–(BUSINESS WIRE)–State Street Corporation (NYSE: STT) today announced a $100 million program to provide low-cost, stable deposit funding to minority... Read more.
JCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its Commitment to the Rare Disease Community
HYOGO, Japan–(BUSINESS WIRE)–Thursday, February 29 is Rare Disease Day (“RDD”). RDD activities aim to raise awareness of rare diseases and to improve... Read more.
Aiosyn Launches Kidney Image Analysis Services Through Its NephroPath Platform to Accelerate Drug Development Studies
NIJMEGEN, Netherlands–(BUSINESS WIRE)–Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney... Read more.
Biomind Labs Announces Unprecedented Positive Results of Phase 2 Clinical Trial of BMND08 for Depression & Anxiety in Alzheimer’s Disease
TORONTO–(BUSINESS WIRE)–Biomind Labs Inc. (“Biomind” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused... Read more.